menu close
www.maplightrx.com

MapLight IPO

NASDAQ: MPLT

Company Profile:

MapLight completed their IPO on October 27, 2025. Now that MapLight is a public company, Nasdaq Private Market does not actively track its performance. The data below is for reference before the company’s IPO.

MapLight is a biopharmaceutical company dedicated to developing targeted treatments for brain disorders. By leveraging proprietary technologies such as optogenetics and STARmap, they aim to identify and modulate specific neural circuits implicated in conditions like schizophrenia, Alzheimer's disease psychosis, and autism spectrum disorder. This approach seeks to improve patient outcomes by addressing the underlying neural mechanisms of these disorders.

Sign up for SecondMarket® to invest in or sell private companies like MapLight before their IPO.
Buy + Sell
  • Headquarters: Redwood City, CA
  • Year Founded: 2019
  • Sector: Health Care
Leverage Your Equity to Help Achieve More.

MapLight Funding Pre-IPO

Gain insights into MapLight funding history prior to their IPO, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Financing Round Date Amount Price per share* Valuation*
Series D Jul 18, 2025 188.19M
Price
Valuation
Series C Nov 02, 2023 55.00M
Price
Valuation
Series C Jul 05, 2023 50.00M
Price
Valuation
Series B Oct 25, 2022 21.20M
Price
Valuation
Series C Oct 25, 2022 12.00M
Price
Valuation
Series B Feb 23, 2021 31.80M
Price
Valuation
Series A Aug 23, 2019 16.00M
Price
Valuation
Series A Feb 22, 2019 5.00M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D®

Leverage Your Equity to Help Achieve More.

MapLight Management Team - Prior to IPO

  • Chief Discovery Officer

    Anatol Kreitzer

  • Board Member

    Timothy Garnett

  • Board Member

    Robert C. Malenka

  • Chief Administrative Officer, Chief Accounting Officer

    Jonathan Gillis

  • Board Member

    George Pavlov

  • Chief Medical Officer

    Erin Pennock Foff

  • Board Member

    Jim Trenkle

  • CFO

    Vishwas Setia

  • CEO, Board Member, Founder

    Christopher A Kroeger

  • Chief Scientific Officer

    James Lillie

  • Board Member

    Peter Tuxen Bisgaard

Learn More About MapLight Stock

Buy MapLight Stock
01

MapLight became publicly traded following its IPO on October 27, 2025, its shares now trade on public stock exchanges under the ticker symbol NASDAQ: MPLT. Before the IPO, MapLight stock was privately held and available only through private market transactions.

If you’re an accredited investor looking to purchase pre-IPO shares in a private company, Nasdaq Private Market can help you get started. Learn more about investing in the private market or sign up for free to explore available opportunities. Learn more about how private company shares trade prior to an IPO on our investors page.

Sell MapLight Stock
02

Following its IPO on October 27, 2025, MapLight shares trade on public stock exchanges, allowing shareholders to sell stock through a traditional brokerage.

If you currently hold shares in a private company, Nasdaq Private Market may be able to help you explore your sell private company stock. Our platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To understand how employees sell shares before a company goes public, visit the Employee Shareholders page.

MapLight Stock Price
03

Following the IPO, MapLight stock prices can now be viewed publicly on major exchanges. Investors and interested parties can find the current stock price by searching MapLight’s ticker symbol on financial platforms such as Nasdaq.com or through their preferred brokerage platform.

MapLight Stock Ticker Symbol
04

Following its IPO on October 27, 2025, MapLight stock now trades on public markets under the ticker symbol NASDAQ: MPLT. You can view real-time stock information through widely used financial data platforms.

Criteria to Sell MapLight Stock
05

Following the MapLight IPO, public shares can be sold through any brokerage.

Nasdaq Private Market works with employees, ex-employees, and other private company shareholders of pre-IPO companies to sell their shares. The Nasdaq Private Market platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To learn more about how to sell private company stock, visit the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in MapLight Stock
06

Following MapLight’s initial public offering on October 27, 2025, its shares are now listed on a public exchange and available for purchase through a brokerage account. Investors interested in buying MapLight stock can do so through their preferred broker, just as they would with any other publicly traded security.

Nasdaq Private Market continues to work with investors seeking exposure to private company opportunities prior to IPO. Through structured transactions and curated offerings, investors can participate in private market activity before companies enter the public markets.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

MapLight Stock Settlement
07

Since MapLight is now publicly traded, public-market share transfers and settlement occur automatically through a brokerage or exchange.

Nasdaq Private Market supports transfer and settlement for privately held company equity. In order to buy or sell private company stock, share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patented Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

MapLight IPO
08

MapLight completed its IPO on October 27, 2025, and is now publicly available through major financial sources.

Sign up for SecondMarket® to invest in or sell private companies like MapLight before their IPO.
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Tonal Strong-Logo

Tonal

Delivers AI-powered strength training with digital weights and personalized coaching.

Curology-Logo

Curology

Offers personalized prescription skin care medications delivered directly to you.

Devoted

Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.

Cerebral

Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Hinge Health-Logo

Hinge Health

Digital clinic for back, joint, and muscle pain.

Benchling-Logo

Benchling

Cloud based platform for research and development in biotechnology.

Lyra Healthcare-Logo

Lyra

Digital health startup using technology to connect companies and employees to mental health providers.

Source: Nasdaq Private Market Tape D®